IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

REBECCA CHEN

Allopathic & Osteopathic Physicians Dermatology

NPI
1972131431
CMS profile
11632397
Location
PALO ALTO, CA

General Payments · PY2024

$2,652.68

  • Reported across 55 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,652.68

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Dermatology CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,571.82 54
Education $80.86 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
SUN PHARMACEUTICAL INDUSTRIES INC. $495.69 4
Dermavant Sciences, Inc. $348.09 8
E.R. Squibb & Sons, L.L.C. $279.51 7
Janssen Scientific Affairs, LLC $270.90 2
Regeneron Healthcare Solutions, Inc. $246.97 6
Galderma Laboratories, L.P. $199.54 3
Lilly USA, LLC $135.11 2
UCB, Inc. $124.39 1
Janssen Biotech, Inc. $107.55 5
Boehringer Ingelheim Pharmaceuticals, Inc. $98.41 1
GENZYME CORPORATION $82.55 3
ABBVIE INC. $70.75 4
Biofrontera Inc. $60.40 3
NOVARTIS PHARMACEUTICALS CORPORATION $53.52 2
Incyte Corporation $34.44 2
CHIESI USA, INC. $27.22 1
Almirall LLC $17.64 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $2,652.68 55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $25.00 04/15/2024 Food and Beverage Undisputed 01/23/2026 1103453436 CMS
ABBVIE INC. $19.11 09/28/2024 Food and Beverage Undisputed 01/23/2026 1103453438 CMS
ABBVIE INC. $13.10 11/02/2024 Food and Beverage Undisputed 01/23/2026 1103453440 CMS
ABBVIE INC. $13.54 11/28/2024 Food and Beverage Undisputed 01/23/2026 1103453442 CMS
Almirall LLC $17.64 10/26/2024 Food and Beverage Undisputed 01/23/2026 1120643453 CMS
Biofrontera Inc. $21.97 03/15/2024 Food and Beverage Undisputed 01/23/2026 1092759839 CMS
Biofrontera Inc. $12.20 03/22/2024 Food and Beverage Undisputed 01/23/2026 1089609608 CMS
Biofrontera Inc. $26.23 12/18/2024 Food and Beverage Undisputed 01/23/2026 1111506082 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $98.41 02/26/2024 Food and Beverage Undisputed 01/23/2026 1118255494 CMS
Chiesi USA, Inc. $27.22 04/04/2024 Food and Beverage Undisputed 01/23/2026 1151803273 CMS
Dermavant Sciences, Inc. $136.67 01/17/2024 Food and Beverage Undisputed 01/23/2026 1127857137 CMS
Dermavant Sciences, Inc. $28.64 03/29/2024 Food and Beverage Undisputed 01/23/2026 1127857139 CMS
Dermavant Sciences, Inc. $24.21 04/07/2024 Food and Beverage Undisputed 01/23/2026 1127857141 CMS
Dermavant Sciences, Inc. $31.62 04/20/2024 Food and Beverage Undisputed 01/23/2026 1127857143 CMS
Dermavant Sciences, Inc. $6.41 08/28/2024 Food and Beverage Undisputed 01/23/2026 1127857145 CMS
Dermavant Sciences, Inc. $10.68 09/11/2024 Food and Beverage Undisputed 01/23/2026 1127857147 CMS
Dermavant Sciences, Inc. $8.26 11/15/2024 Food and Beverage Undisputed 01/23/2026 1127857149 CMS
Dermavant Sciences, Inc. $101.60 12/03/2024 Food and Beverage Undisputed 01/23/2026 1127857151 CMS
E.R. Squibb & Sons, L.L.C. $114.32 02/23/2024 Food and Beverage Undisputed 01/23/2026 1101354274 CMS
E.R. Squibb & Sons, L.L.C. $21.36 03/22/2024 Food and Beverage Undisputed 01/23/2026 1101354292 CMS
E.R. Squibb & Sons, L.L.C. $18.03 04/01/2024 Food and Beverage Undisputed 01/23/2026 1101354294 CMS
E.R. Squibb & Sons, L.L.C. $25.00 04/26/2024 Food and Beverage Undisputed 01/23/2026 1101354296 CMS
E.R. Squibb & Sons, L.L.C. $45.24 05/06/2024 Food and Beverage Undisputed 01/23/2026 1101354314 CMS
E.R. Squibb & Sons, L.L.C. $36.27 06/26/2024 Food and Beverage Undisputed 01/23/2026 1101354326 CMS
E.R. Squibb & Sons, L.L.C. $19.29 12/06/2024 Food and Beverage Undisputed 01/23/2026 1101354384 CMS
Galderma Laboratories, L.P. $144.04 01/24/2024 Food and Beverage Undisputed 01/23/2026 1145290220 CMS
Galderma Laboratories, L.P. $22.17 08/30/2024 Food and Beverage Undisputed 01/23/2026 1145290222 CMS
Galderma Laboratories, L.P. $33.33 11/01/2024 Food and Beverage Undisputed 01/23/2026 1145290224 CMS
GENZYME CORPORATION $31.11 01/22/2024 Food and Beverage Undisputed 01/23/2026 1139961747 CMS
GENZYME CORPORATION $31.07 02/23/2024 Food and Beverage Undisputed 01/23/2026 1139961751 CMS
GENZYME CORPORATION $20.37 06/03/2024 Food and Beverage Undisputed 01/23/2026 1139961771 CMS
Incyte Corporation $13.63 11/09/2024 Food and Beverage Undisputed 01/23/2026 1141287266 CMS
Incyte Corporation $20.81 12/06/2024 Food and Beverage Undisputed 01/23/2026 1141287566 CMS
Janssen Biotech, Inc. $22.00 05/20/2024 Food and Beverage Undisputed 01/23/2026 1078312450 CMS
Janssen Biotech, Inc. $16.89 10/04/2024 Food and Beverage Undisputed 01/23/2026 1078312444 CMS
Janssen Biotech, Inc. $25.22 10/16/2024 Food and Beverage Undisputed 01/23/2026 1078312736 CMS
Janssen Biotech, Inc. $14.56 10/25/2024 Food and Beverage Undisputed 01/23/2026 1078312570 CMS
Janssen Biotech, Inc. $28.88 11/09/2024 Food and Beverage Undisputed 01/23/2026 1078312608 CMS
Janssen Scientific Affairs, LLC $145.24 03/10/2024 Food and Beverage Undisputed 01/23/2026 1078845399 CMS
Janssen Scientific Affairs, LLC $125.66 07/17/2024 Food and Beverage Undisputed 01/23/2026 1078845401 CMS
Lilly USA, LLC $27.04 01/28/2024 Food and Beverage Undisputed 01/23/2026 1135352692 CMS
Lilly USA, LLC $108.07 02/21/2024 Food and Beverage Undisputed 01/23/2026 1135362883 CMS
Novartis Pharmaceuticals Corporation $32.21 03/27/2024 Food and Beverage Undisputed 01/23/2026 1086684247 CMS
Novartis Pharmaceuticals Corporation $21.31 09/20/2024 Food and Beverage Undisputed 01/23/2026 1086684251 CMS
Regeneron Healthcare Solutions, Inc. $8.41 08/28/2024 Food and Beverage Undisputed 01/23/2026 1114023480 CMS
Regeneron Healthcare Solutions, Inc. $80.86 09/26/2024 Education Undisputed 01/23/2026 1114023482 CMS
Regeneron Healthcare Solutions, Inc. $13.81 09/27/2024 Food and Beverage Undisputed 01/23/2026 1114023484 CMS
Regeneron Healthcare Solutions, Inc. $125.00 10/25/2024 Food and Beverage Undisputed 01/23/2026 1114023486 CMS
Regeneron Healthcare Solutions, Inc. $8.60 11/15/2024 Food and Beverage Undisputed 01/23/2026 1114023488 CMS
Regeneron Healthcare Solutions, Inc. $10.29 12/18/2024 Food and Beverage Undisputed 01/23/2026 1114023490 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $148.42 01/31/2024 Food and Beverage Undisputed 01/23/2026 1152193622 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $148.19 02/05/2024 Food and Beverage Undisputed 01/23/2026 1152193616 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $35.49 04/05/2024 Food and Beverage Undisputed 01/23/2026 1152193620 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $163.59 04/26/2024 Food and Beverage Undisputed 01/23/2026 1152193618 CMS
UCB, Inc. $124.39 03/20/2024 Food and Beverage Undisputed 01/23/2026 1143032485 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.